Petroll Andrew E, Walsh Jennifer L, Owczarzak Jill L, McAuliffe Timothy L, Bogart Laura M, Kelly Jeffrey A
Center for AIDS Intervention Research (CAIR), Medical College of Wisconsin, 2071 N. Summit Avenue, Milwaukee, WI, 53202, USA.
Johns Hopkins University, Baltimore, MD, USA.
AIDS Behav. 2017 May;21(5):1256-1267. doi: 10.1007/s10461-016-1625-1.
HIV pre-exposure prophylaxis (PrEP) was FDA approved in 2012, but uptake remains low. To characterize what would facilitate health care providers' increased PrEP prescribing, we conducted a 10-city, online survey of 525 primary care providers (PCPs) and HIV providers (HIVPs) to assess awareness, knowledge, and experience with prescribing PrEP; and, comfort with and barriers to PrEP-related activities. Fewer PCPs than HIVPs had heard of PrEP (76 vs 98%), felt familiar with prescribing PrEP (28 vs. 76%), or had prescribed it (17 vs. 64%). PCPs were less comfortable than HIVPs with PrEP-related activities such as discussing sexual activities (75 vs. 94%), testing for acute HIV (83 vs. 98%), or delivering a new HIV diagnosis (80 vs. 95%). PCPs most frequently identified limited knowledge about PrEP and concerns about insurance coverage as prescribing barriers. PCPs and HIVPs differ in needs that will facilitate their PrEP prescribing. Efforts to increase PrEP uptake will require interventions to increase the knowledge, comfort, and skills of providers to prescribe PrEP.
HIV暴露前预防(PrEP)于2012年获得美国食品药品监督管理局(FDA)批准,但使用率仍然很低。为了明确哪些因素将促进医疗保健提供者增加PrEP处方量,我们对来自10个城市的525名初级保健提供者(PCP)和HIV提供者(HIVP)进行了在线调查,以评估他们对PrEP处方的认知、知识和经验,以及对PrEP相关活动的舒适度和障碍。听说过PrEP的PCP比HIVP少(76%对98%),对开具PrEP处方感到熟悉的比例也较低(28%对76%),实际开具过PrEP处方的比例同样较低(17%对64%)。在PrEP相关活动方面,如讨论性行为(75%对94%)、检测急性HIV(83%对98%)或告知新的HIV诊断结果(80%对95%),PCP比HIVP更不自在。PCP最常指出对PrEP的了解有限以及对保险覆盖范围的担忧是处方障碍。PCP和HIVP在促进他们开具PrEP处方的需求方面存在差异。提高PrEP使用率的努力将需要采取干预措施,以增加提供者开具PrEP的知识、舒适度和技能。